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Nephritogenicity of proteoglycans. II. A model of immune complex
nephritis. Antibodies to glomerular basement membrane, heparan sul-
fate-proteoglycans are nephrotoxic but possess a weak nephritogenic
potential. In order to enhance the nephritogenic potential, the antibod-
ies were intravenously administered into rats presensitized with heter-
ologous rabbit IgG. This resulted in the integration of heterologous and
autologous phases, the two phases characteristic of the traditional
model of nephrotoxic serum nephritis. The presensitization caused a
dramatic shift in the binding characteristics of the heterologous anti-
bodies between the kidney and lymphoid tissues. A proliferative form
of immune complex glomerulonephritis associated with a remarkable
proteinuric response was observed. In addition, a moderate degree of
hematuria was noted as well. The proteinuria was largely complement-
dependent and may possibly be cell-mediated as well. The proteinuria
became severe with increasing production of host IgG antibodies and
with their subsequent sequestration in the glomeruli. The predominant
glomerular lesions were in the form of epimembranous/subepithelial
immune deposits, which became more frequent with timely increasing
titer of host autologous IgG antibodies. These findings indicate that
antibodies to heparan sulfate-proteoglycan, an authentic component of
the basement membrane, are capable of mediating a glomerular injury
with acquisition of nephritogenic potential in an appropriate environ-
ment of the host. At present, it seems that this is the sole constituent of
the basement membrane whose antibodies are capable of inducing an
immune complex nephritis.
Basement membrane, a macromolecular complex of a multi-
tude of glycoproteins, is an essential component of the glomer-
ular capillaries; in concert with its anchored cellular elements it
serves as a barrier to the circulating plasma proteins [1, 2]. At
times, antibodies directed against glomerular basement mem-
brane (GBM) appear in circulation in altered immune states
such as Goodpasture's syndrome [3]. These antibodies bind to
the GBM and induce a form of proliferative glomerulonephritis
associated with certain defects in the barrier properties of the
capillaries which lead to proteinuria and hematuria [4]. A more
or less similar type of lesions can be induced in rats by injection
of anti-GBM antibodies [3, 5—7]. Thus, the intravenous admin-
istration of these antibodies results in a severe and self-
perpetuating disease process, traditionally termed nephrotoxic
nephritis (NTN). The NTN disease runs a biphasic course
which has been well characterized by several investigators and
is detailed in many recent reviews [3, 8]. In the heterologous
phase, intravenously administered heterologous antibodies rap-
idly bind to the GBM, cause complement activation [9, 10] and
its sequestration in the glomerulus, polymorphonuclear neutro-
phil (PMN) infiltration, exfoliation of the endothelium [11—15],
and proteinuria [16, 17]. After 7 to 10 days, the autologous
phase ensues, and it is characterized by a humoral production
of host IgG antibodies to the GBM-bound heterologous anti-
body [18], further activation and sequestration of C3 [18, 19],
proliferation of glomerular cells, accumulation of monocytes
[19, 20], and leading to a heightened proteinuric response [17,
21]. Although a proliferative form of glomerulonephritis devel-
ops during the autologous phase, immune complex deposits as
seen in other forms of nephritides, such as Heymann nephritis
[22—25], usually do not develop.
In recent years, much attention has focused on delineating
the component, the antibodies to which could be held respon-
sible for the nephritogenicity of the GBM. The GBM compo-
nents which had been so far investigated include type IV
collagen [26—29] and its non-collagenous domain [30], laminin
[31—33], and proteoglycans [34—37]. Although the GBM as a
whole is highly antigenic and its antibodies quite nephrotoxic
[3, 5—8], its individual components have been found to be
weakly nephritogenic [29, 32, 36, 37].
Previously we investigated the nephritogenic potential of the
antibodies to the core-peptide (Mr = 18,000) of heparan sulfate-
proteoglycan (HS-PG) and reported that the antibodies were
weakly nephrotoxic when administered intravenously to unsen-
sitized animals [36]. In spite of the remarkable changes in the
GBM, no proteinuric response was observed in either the
heterologous or autologous phase. In this study, we examined
the nephritogenic potential of antibodies in a presensitized/
hyperimmune state of the animals. In this scenario, an accen-
tuation and acceleration of the autologous phase with evolution
of a peculiar type of immune complex nephritis was observed.
Thus, we include in this investigation the description of the
lesions and some of the pathogenetic mechanisms leading to the
development of such an immune complex nephritis.
Methods
Preparation of anti-HS-PG antibody
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Polyclonal antibodies against the core protein (Mr 18,000)
of GBM. HS-PG were raised in rabbits and IgG fraction
obtained from the antisera. The preparation of the antigen and
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antibody and the authenticity of their specificities have been
detailed in previous publications [35, 36, 38].
Protocol of nephritogenicity experiments with
anti-HS-PG antibody
Forty-eight Fischer female rats, weighing about 50 g each,
were used for these experiments. The rats were preimmunized
twice on days 1 and 4 with normal rabbit IgG (0.5 mg/lOO g body
wt) in complete Freund's adjuvant by intracutaneous injections
into their foot pads. Seven days after the first immunization
injection, 32 of the animals received intravenous injections of
saline containing anti-HS-PG antibody (50 mg/lOO g body wt).
Sixteen control rats received the same amount of IgG fraction-
ated from normal rabbit serum. The animals were sacrificed in
batches of four experimental and two controls at 1 hour, 1 and
3 days, and 1, 2, 4, 6, and 8 weeks after administration of
intravenous injections.
Prior to sacrifice, rats were transferred to metabolic cages for
24-hour urine collection with access to water ad libitum only.
The urinary proteins were determined by biuret method [391.
The presence of blood in the urine was determined by hema-
stick. Also, numbers of RBCs per high power field of the light
microscope were counted in the centrifuged urinary sediment.
The rat kidneys were processed for morphologic studies, which
included immunofluorescent, light, and electron microscopy.
Morphologic studies
Direct immunofluorescence studies were performed on 4-jim-
thick unfixed cryostat sections. Sections were air-dried, washed
with phosphate buffered saline (PBS), incubated with either of
the following antisera: FITC anti-rabbit IgO, rat IgG, C3 and
fibrinogen (Cooper Biomedical Inc., Malvern, Pennsylvania,
USA), and examined by immunofluorescent microscopy. The
intensity of fluorescence was graded on a (—) to (+ ++ +) scale.
For light microscopy, renal cortical pieces were fixed in buf-
fered formalin; 3-jim-thick sections were made and stained with
hematoxylin and eosin. Kidney tissues, fixed either in
Karnovsky's fixative or 1% glutaraldehyde plus 0.2% tannic
Table 1. Summary of immunofluorescent findings
Rabbit
Time Rat igo Rat C3 Fibrinogen IgO
1 hr (—) (l)a () (±±±±)a
iday (—) (±) () (++±)S
3 days ()a () (—) (++++)
1 week (÷+)a (+)l (+) (÷++÷)a
2 weeks (÷÷÷)a (+÷)b (+) (÷+÷+)a
4 weeks (++++)t (++)' (+) (+++)a
6 weeks
8 weeks
(++++)"
(++++t
(+++)b(+++)b (+)(+) (÷÷+)a(++)b
a Linear patternb Mixture of linear and granular pattern
acid in 0.1 M cacodylate buffer, pH 7.4, were processed for
electron microscopy.
Although it was reported previously [36] that the administra-
tion of anti-HS-PG antibodies does not cause significant renal
immunopathologic alterations or proteinuria, the intervention
of preimmunization resulted in remarkable glomerular changes;
this necessitated some further exploratory studies to delineate
the mechanisms involved in the induction of immune complex
nephritis and proteinuric response in this model. These studies
included antibody binding/clearance experiments, measure-
ment of host antibody production response, and the role of
complement or inflammatory cells in the causation of immune
complex nephritis and proteinuria.
Antibody clearance and binding studies
The IgO fraction of the antibody and normal rabbit IgG were
radioiodinated with '251-Na by lactoperoxidase : glucose oxidase
method, and the free iodine was removed by exhaustive dialysis
against normal saline and Sephadex G-25 chromatography as
previously described [36, 40].
For clearance experiments, 16 rats, each weighing 50 g, were
divided into four groups with four rats in each group. In the first
group, the rats were intravenously injected with 100 jig of
radioiodinated normal rabbit IgG; in the second group, they
were preimmunized a week prior to the injection of radioiodi-
nated normal rabbit IgG. The rats in the third group received
100 jig of radioiodinated anti-HS-PG antibody, and those of the
fourth group were preimmunized before receiving the same
dose of radioiodinated antibody. Blood samples were collected
from the tail vein at 10 and 30 minutes, 1, 2, and 6 hours, and 1,
3, 5, and 7 days after the injection. The radioactivities in the
samples were determined by a gamma-counter.
For binding experiments, 16 rats in groups of four, as
categorized in the clearance studies, were used. They were
sacrificed 24 hours after the administration of intravenous
injections of either the radioiodinated anti-HS-PG antibody (50
mg/100 g body wt) or normal rabbit IgO. Their kidneys were
flushed with saline via the abdominal aortic route. They were
then fixed by perfusion with Karnovsky's fixative and proc-
essed for light microscopic autoradiography [40, 41]. Thirty-six
glomeruli from four rat tissues were analyzed in each of the four
groups. The glomeruli were photographed and printed to a final
magnification of x 1500. The autoradiographic grains over the
capillary wall were enumerated. The area of the capillary wall
was determined by point counting method [41], and the grain
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Fig. 1. Daily urinary protein excretions of the presensitized rats after
intravenous administration of the antibody () or normal (•) IgG. The
proteinuric response is seen only in the animals administered with the
antibody.
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Fig. 2. Direct immunofluorescent microscopy of cryostat sections incubated with FITC-conjugated anti-rat IgG (A and B), anti-rat C3 (C and D),
anti-rabbit IgG (E), and anti-rat fibrinogen (F). The kidney tissues were obtained during the initial (A, C, and E) and later (B, D, and F) part of
the anti-HS-PG disease. The arrows in panels B and D indicate the granularity in the fluorescent pattern, while that in panel F indicates fibrinogen
in the Bowman's space. x 600.
density was computed by dividing the total number of grains by Measurement of serum anti-rabbit IgG
total area points. Other organs, such as the lung, liver, spleen,
and lymph nodes, were dissected after the perfusion wash with Twenty female Fischer rats, with four in each group, were
saline, and the radioactivities in them were determined and used. The rats in groups 1, 2, and 3 were preimmunized with
normalized to per-gram of tissue. normal rabbit IgG as described in the nephritogenicity experi-
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Fig. 3. Low-power electron micrograph of the
glomerulus taken from a presensitized animal
administered with anti-HS-PG antibody and
sacrificed one hour later. A concomitant
infiltration by the polymorphonuclear
leukocytes (PMN) and monocytes (MO) is
observed in many capillaries (Cap). The
basement membrane of capillary ioops is
uniformly thin. Ep, epithelium; En,
endothelium; Me, mesangium; RBC,
erythrocyte; US, urinary space. x 3,000.
ments, while the rats in groups 4 and 5 were not immunized.
Seven days later, the rats in groups 3 and 5 received intrave-
nous injections of normal rabbit IgG (50 mg/100 g body wt),
while those in groups 2 and 4 were intravenously injected with
the same dose of antibody. The blood samples were taken 3, 6,
9, 12, and 16 days and 3, 4, 5, 6, 7, and 8 weeks after the
preimmunization. The sera were harvested and anti-rabbit IgG
levels measured by ELISA, as described by Engvall and
Perlmann [421. Briefly, Coster (Cambridge, Massachusetts,
USA) 96-well plates were coated overnight with 100 d of rabbit
IgG (10 g/m1) in PBS, pH 7.4, at 4°C. Nonspecific sites on the
plates were blocked with 2% bovine serum albumin (BSA) in
PBS for one hour. The rat serum was diluted (I : 10 to I : 10,000)
with PBS containing 1% BSA, and 100 d of diluted serum was
transferred to the wells and incubated for two hours. The plates
were washed three times with PBS containing 1% BSA, 0.05%
Tween 20, and then reincubated for two hours with 1000-fold
diluted 100 t1 of anti-rat IgG conjugated with peroxidase
(Cooper Biomedical Inc., Malvern, Pennsylvania, USA). After
rewashing the plates, 200 d of substrate solution (4 mg/mI
0-phenylenediamine and 0.01% H202 in 0.1 M sodium citrate,
pH 5.0) was added. The reaction was terminated with the
addition of 50 d of 5 M H2S04. After one hour, absorbance was
read at 450 nm with an EIA reader (Biorad Laboratories,
Richmond, California, USA). In preliminary experiments, the
titration curves obtained with individual sera were parallel.
Therefore, the A450 of a 1:100 dilution of the individual sera was
measured and compared to the A450 of a highest titer reference
serum. The results were expressed as percent absorbance of the
reference serum at 1:100 dilution.
Completnent-depletion studies
Ten rats weighing 100 g each were preimmunized as de-
scribed above with normal rabbit IgG. They were then comple-
ment-depleted by multiple intraperitoneal (i.p.) injections of
cobra venom factor (CVF; Cordis Laboratories Inc., Florida,
USA). A total of 300 U/kg per animal was used as an initial
dose. Twenty-four hours later, anti-HS-PG antibody (50 mg/100
g body wt) was administered intravenously, following which
daily injections of CVF (100 U/kg, i.p.) were given for 11 days.
The above protocol is essentially the same as previously
described [101. Daily blood samples were taken, and C3 levels
were measured by Mancini single radial imthunodiffusion meth-
od [43]. The C3 levels were expressed as a percentage of the
baseline C3 levels in each animal measured before antibody
injection. A control group of ten rats was preimmunized and
injected with the same dose of antibody but was not comple-
ment-depleted. Urinary protein excretions were measured in
both groups of animals on days 4, 7, and 11. The animals were
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Table 2. Grain density distribution of radioiodinated ligan
glomerular capillary wall
d in the
Group Mean SD P
I.
II.
Normal IgG 0.75 0.40
Presensitized + normal IgG 0.73 0.47 NS
III.
IV.
Antibody 15.09 3.26
Presensitized + antibody 11.17 1.88 <0 005
each rat kidneys were utilized for the analysis. The PMN
leukocytes were counted in the capillaries and expressed as
mean SD per glomerular section.
Results
Urinary protein excretion
Proteinuric response was observed within a week after the
administration of the antibody. The response gradually in-
creased, and by the sixth week all the rats were significantly
proteinuric (Fig. 1). Control rats, injected with normal IgG, did
not become proteinuric, and their mean urinary protein excre-
tions remained below 2 mg/day/100 g body wt throughout the
investigatory period. Besides being proteinuric, the rats were
hematuric as well. The presence of blood in the urine was noted
as early as a week after the administration of the antibody. Ten
to 15 RBCs per high power field in the urinary sediment was a
usual finding during the course of the disease.
Morphologic studies of nephritogenicizy experiments
Fig. 4. Electron micrograph of portion of the glomerulus from a
presensitized animal sacrificed one hour after administration of anti-
HS-PG. Both the polymorphonuclear leukocytes (PMN) and mono-
cytes (MO) are seen in the capillaries (Cap). In areas, the endothelial
cells are partially detached, and monocytes and PMNs are seen in
contact with the basement membrane of the capillary loops. Ep,
epithelium; En, endothelium; Me, mesangium; US, urinary space.
x 5,000.
sacrificed on day 11, and their kidneys were processed for
immunofluorescent, light, and electron microscopy.
Next, relationship between the complement and glomerular
polymorphonuclear leukocytic infiltration was investigated in
this model. The rats were categorized into three groups. The
first group consisted of six rats injected with anti-HS-PG
antibody (50 mg/l00 g body wt), and the ones in the second
group (six rats) were preimmunized with normal rabbit IgG
prior to the administration of the antibody. The third group (six
rats) was preimmunized and complement-depleted 24 hours
prior to the intravenous injection of the antibody. The rats were
sacrificed six hours after the injection of the antibody: the time
interval when maximum PMN infiltration in the glomeruli is
expected. Serum C3 levels were determined. Their kidneys
were processed for light microscopy. About 200 glomeruli from
By light microscopy, a moderate number of PMNs and
mononuclear cells was seen in the glomerular capillaries within
an hour after the administration of the antibody. The infiltration
seemed to regress by 24 hours. By the third day, occasional
PMNs were seen in the capillaries; in contrast, mononuclear
cell infiltration persisted throughout the course of the disease.
Mild mesangial hypercellularity and focal increase in the mes-
angial matrices were seen as early as one week. The thickening
of glomerular capillaries was observed after about two weeks.
No significant pathologic change was seen in the control ani-
mals.
Immunofluorescent microscopic findings are summarized in
Table 1. Initially, that is, three days after intravenous injection
of the antibody, rat IgG had linear fluorescence, and the
intensity of staining increased with progression of time (Fig.
2A). By four weeks, a mixed pattern of fluorescence, linear as
well as granular, was observed (Fig. 2B). The tubular basement
membrane and Bowman's capsule did not fluoresce. Rat C3 was
transiently positive for 24 hours, and a weak fluorescence was
observed (Fig. 2C). After being negative for a week, C3 reac-
tivity regained, and its presence coincided with the onset of
proteinuria (Fig. 2D). Also, a correlation between the intensity
of C3 staining and the degree of proteinuria was noted as well.
Thus, in subsequent weeks, increase in the intensity of C3
staining was concomitantly associated with the accentuation of
the proteinuric response. The rabbit IgG had a linear pattern of
fluorescence, and its intensity lessened with passage of time
(Fig. 2E). At eight weeks, some granularity in the linear
fluorescence was also observed. Focal staining of the capillary
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Table 3. Bindings of radioiodinated ligands in various organs one hour after intravenous injection (sg, mean SD)
Lymph
Group Kidney Lung Liver Spleen node
I. Normal IgG 21 2 50 7 73 14 94 25 69 16
II. Presensitized + normal IgG 16 1 24 4 71 14 56 22 139 30
III. Antibody 180 7 169 39 503 52 449 98 363 10
IV. Presensitized + antibody 110 12 130 16 415 31 340 77 989 62
Fig. 5. Electron micrographs of portions of the
gloineruli taken from the rats sacrificed 3 (A) and 7
(B) days after the administration of the antibody. In
panel A, mostly the monocytes (MO) are seen in the
glomerular capillaries (Cap). The mesangial cells
(Me) are increased, and occasional mitosis (MI) is
seen. In panel B, numerous RBCs and degenerated
epithelial (Ep) cellular element-like lysosomes (L)
and mitochondria (M) are seen in the urinary space
(US), Epithelial foot processes are effaced at places,
and occasional subepithelial deposits are seen as
well. En, endothelium; BC, Bowman's capsule.
x 5,000.
wall and Bowman's space was observed when stained with
anti-fibrinogen (Fig. 2F).
Multitudinous glomerular lesions were observed by electron
microscopy. A moderate infiltration of both the PMNs and
monocytes was observed an hour after the injection of the
antibody (Fig. 3). The cytoplasmic pseudopods of these cells
were seen apposed to the GBM, extending through the endo-
thelial fenestrae (Figs. 3, 4). In areas, the endothelial cells were
swollen and detached from the GBM. The magnitude of cellular
infiltration varied between 0 and 4 cells per capillary loop. The
PMN cellular infiltration regressed, while that of the monocytes
persisted (Fig. 5A) only in the capillary lumina or in the
mesangiurn. A week later, focal mesangial hypercellularity (Fig.
6A) with increase in the mesangial matrices (Fig. 6B) ensued.
At this time interval, numerous RBCs were seen in the urinary
space (Fig. SB).
A most remarkable finding was the presence of immune
complex deposits in various regions of the glomerulus. Initially,
the deposits were seen on both sides of the GBM in the lamina
rara interna (LRI) and externa (LRE) (Fig. 7A). However, the
deposits in the subendothelial regions were inconspicuous and
disappeared with passage of time. Later, during the course of
the disease, the subepithelial deposits in the LRE grew larger,
became prominent, and coalesced with one another (Fig. 7B).
With further progression, the deposits became incorporated in
the GBM and began to resolve. After six to eight weeks, the
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Fig. 6. Electron ,nicrographs of portions of the
glomeruli taken from the rats sacr(ficed 7 (A) and 14
(B) days after the administration of the antibody.
Panel A is taken from an area exhibiting mesangial
(Me) hypercellularity, while panel B includes regions
of thickened basement membrane and increased
mesangial matrices (MM) impregnated with
electron-dense deposits, The electron-dense deposits
are seen in the basement membrane (arrows) as well
as in the mesangial matrices (asterisks). US, urinary
space; Cap, capillary; Ep, epithelium; En,
endothelium. x 5,000.
Table 4. Number of polymorphonuclear leukocytes per glomerular
section
Polymorphs
Group mean SD P
Antibody
Presensitized + antibody
Presensitized + CVF + antibody
0.45 0.02
}0.78 0.03
1
0.43 0.021
<0.001
<0.001
basement membranes of the capillary loops were irregularly
thickened and had translucent regions, indicative of reabsorbed
deposits. At about the same time, the immune complex deposits
were often seen in the mesangial matrices associated with
hypercellularity. During the course of the formation/resolution
of the immune deposits, noticeable changes were observed in
the visceral epithelium. The changes included approximation/
fusion of the visceral epithelial foot process, aggregation of
cytoplasmic actin filaments (Fig. 7C), focal detachments, and
an increase in the microtubules and lysosomes.
It is interesting to note here that immune deposits have been
formed in the GBM of a presensitized rat after administration of
the antibodies, directed towards an "integral" and "authentic"
component of the basement membrane, that is, HS-PG. Since
the injection of anti-HS-PG antibodies alone does not result in
the formation of immune deposits, it became mandatory to
investigate some of the mechanisms by which these immune
complexes may be formed in the GBM of a presensitized
animal.
Antibody clearance and binding studies
First, the clearance rates of the normal IgG and of the
antibody in unsensitized and presensitized animals were deter-
mined. It was anticipated that the immune complex deposits
may have been formed due to a delayed clearance of the
antibody as compared to normal IgG. As a result, there would
be a prolonged exposure of the antibody to the GBM with the
subsequent formation of an immune deposit. However, the
clearance rate for antibody turned out to be much faster for the
presensitized animals as compared to those which were not
sensitized (Fig. 8). In addition, a relatively faster clearance rate
of the antibody, as compared to normal IgG, was observed. The
differences in the clearance rates among various groups were
quite evident for a few hours after administration of the
radioiodinated ligands, but these differences became minimal
rn us -
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merular capillary loops (Figs. 10 A and B). Normal IgG mini-
mally binds to the capillary wall (Figs. 10 C and D). Here, too,
the binding of antibody, as reflected by grain-density distribu-
tion (Table 2), was much lower in animals which were presensi-
tized (Fig. lOB) as compared to the control (Fig. bA).
Because of the divergence in clearance and binding data, that
is, faster clearance and lesser binding of the antibody in the
kidney, a limited examination of the ligand binding or seques-
tration in other organs was investigated (Table 3). In general,
values for the antibody binding were higher than those of the
normal IgG. The binding of antibody in lungs, liver, and spleen
was more or less similar between presensitized and nonsensit-
ized animals. Noticeable differences were observed in the
lymph nodes, where the binding or uptake of the ligand was
quite high in the presensitized group. This led us to the
suggestion that the ready uptake of the antibody in a presensi-
tized animal by the lymphoid system may generate another set
of host antibodies directed against the administered anti-HS-PG
antibodies. In doing so, the host antibodies either may bind to
the previously implanted anti-HS-PG antibody or complex with
the latter in circulation and lodge in the GBM with the forma-
tion of an immune complex deposit ultimately. In view of these
considerations, the serum levels of anti-rabbit IgG were mea-
sured.
Measurement of anti-rabbit IgG
Fig. 7. Electron micrographs of portion of gloinerular capillaries (Cap)
taken from rats sacr/1ced 1 (A), 3 (B), and 6 (C) weeks after the
administration of anti-HS-PG antibody. At one week (A), the deposits
(arrows) are seen in both the subendothelial and subepithelial regions of
the capillaries. At 3 weeks (B), the deposits (arrows) are seen mainly in
the subepithelial regions. At 6 weeks (C), the deposits are reabsorbed,
and these regions are represented by translucent areas (arrows). Also,
extensive effacement of foot processes (fp) and aggregation of epithelial
(Ep) cytoplasmic filaments (Fi) are seen. En, endothelium; GBM,
glomerular basement membrane; US, urinary space. x 15,000.
by 24 hours and disappeared by day 7 (Fig. 8). Next, the binding
of various ligands to the GBM was investigated.
An assumption was made that the antibody binding may be
enhanced in presensitized animals; this may explain the forma-
tion of an immune deposit. On the contrary, the antibody
binding to the renal tissues was much less in the presensitized
rats when compared with the unsensitized ones (Fig. 9). The
binding of the normal IgG was minimal, irrespective of whether
or not the animal was presensitized. The ligand binding to the
renal gbomeruli or GBM was confirmed by light-microscopic
autoradiography (Fig. 10, Table 2). The ligand binding is seen as
black-silver grains by tissue autoradiography. The radioiodi-
nated antibody binding was observed exclusively on the gb-
As indicated above, the possibility of accentuated production
of host antibodies was entertained, and, therefore, the titer of
anti-rabbit IgG was determined in various groups of rats. The
presence of anti-rabbit IgG in the sera was detected in the
presensitized rats about six days after the preimmunization
(Fig. 11). No differences were observed in the titer of the
presensitized animals given either the antibody or the IgG.
Nevertheless, the anti-rabbit-antibody titers were dramatically
lower in the animals which were not sensitized. The titers did
not rise significantly from the baseline for eight weeks. Next,
attention was devoted to the mechanisms involved in the
causation of proteinuria in this model.
Complement-depletion studies
By the protocol of daily intraperitoneal injections of CVF, the
animals essentially remained decomplemented for five days.
Thereafter, the complement levels rose gradually but remained
below 20% of the total or pretreatment levels for two weeks
(Fig. 12). The urinary protein excretion was also significantly
lower in the decomplemented group of rats. The magnitude of
proteinuria remained quite minimal for the duration the animals
had low serum C3 levels.
By immunofluorescent microscopy, C3 reactivity was absent
in the glomeruli from decomplemented animals (Fig. 13 C vs.
D). However, no differences in the reactivities with anti-rat or
rabbit IgG were observed between CVF-injected or untreated
animals (Fig. 13 A and B). A definite correlation was observed
among serum complement level, C3 deposition in the kidney,
and proteinuria. Among the ten rats injected with CYF, seven
rats whose complement levels remained below 30% of the
pretreatment level had glomeruli unreactive towards C3 and
showed no spillage of protein in their unnes. Three rats, whose
serum complement levels rose to 40% of the pretreatment level,
had gbomeruli reactive towards C3 and excreted moderate
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Fig. 8. Percent clearance of the antibody or
normal IgG from the circulation of
unsensitized and presensitized animals at
various time intervals. The sensitization
process enhances the clearance of IgG or
antibody. Symbols are: (U) normal IgG; (•)
antibody; (V) presensitized + normal IgG; (•)
presensitized + antibody.
Experimental Control Experimental Control
- '-
Unsensitized Presensitized
Fig. 9. Renal binding of radiolodinated antibody or normal !gG in
unsensitized and presensitized rats. The sensitization reduces the renal
binding of normal IgG and of the antibody.
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amounts of protein in the urine. The decomplementation did not
influence the immune complex deposition or formation. No
differences were observed in the frequency of electron-dense
deposits between the control and experimental groups by
electron microscopy.
To determine the relationship between the PMNs and com-
plement sequestration, number of PMNs in the glomeruli from
various groups were enumerated. The number of PMNs per
glomerulus was about twofold higher in the group of animals
which were presensitized prior to the administration of anti-
body as compared to those which concomitantly received CVF
or were injected with antibody alone (Table 4). Since the
decomplementation reduced the cellular infiltrates to a certain
degree, it meant that the latter process may be complement-
dependent.
Discussion
The data included in this investigation indicate that the
administration of antibodies directed towards one of the integral
components of the GBM, that is, HS-PG, under appropriate
conditions induces an immune complex glomerulonephritis that
is associated with a dramatic proteinuric response and a certain
degree of hematuria. The immunopathologic changes, protein-
uria, and hematuria seem to be mainly confined to the accen-
tuated autologous phase of the disease. With progression of
time, the disease becomes severe, and there is an increased
production of host antibodies with their deposition in the
glomerulus.
The noticeable feature of anti-H S-PG nephritis appears to be
membranous (subepithelial) lesions. The lesions are not usually
seen in the NTN disease induced by the administration of
antibodies directed against purified GBM or its constituents,
that is, type IV collagen or laminin. As the NTN serum used
was directed against the whole purified GBM preparation, the
question arises: why these membranous lesions were not ob-
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Fig. 10. Light microscopic autoradiograms from glomeruli of kidneys of unsensitized (A and C) and presensitized (B and U) rats that received
anti-HS-PG antibody (A and B) or normal IgG (C and D), The antibody (arrows) is seen binding uniformly to the capillaties (Cap), while minimal
binding of normal IgG is observed. The presensitization reduces (A vs. B) the binding of antibody to the glomerular capillaries (Cap). US, urinary
space. x 750.
served? The only plausible explanation would be that the
HS-PG was lost during the preparation of the antigen (GBM).
The core-protein of HS-PG is extremely susceptible to proteo-
lysis and is very readily degradable [35, 36]; therefore, an
extreme care is usually needed to recover the macromolecular
form of intact HS-PG from the glomerular preparations. How-
ever, a few indeterminate membranous lesions develop when
NTN-antiserum, directed against "whole" kidney cortex, is
used [21]. In this study, the development of lesions may be due
to the contamination of NTN serum by the antibodies directed
against the Heymann antigen (a proximal brush border glyco-
protein). The membranous lesions are regarded as the hallmark
of Heymann nephropathy. In any event, it appears that besides
Heymann antigen, the anti-HS-PG antibodies also play a role in
the evolution of membranous nephropathy. Furthermore, it
seems that HS-PG is the sole constituent of the GBM whose
antibodies are capable of inducing membranous nephritis. The
possible mechanisms responsible for the evolution of anti-HS-
PG nephropathy are elucidated in the accompanying paper [44].
The second feature of this model pertains to the accentuated
proteinuric response. A variety of factors has been described in
various models which attribute to the glomerular insult and as
the cause of proteinuria. Besides PMNs [10, 16] and monocytes
[16, 20, 21, 45], the degree of proteinuria and glomerular injury
can be influenced by the amount of antibody bound to the
glomerulus or its persistence in circulation [16, 33, 46], charge
on the antigen-antibody complexes [46—50], complement acti-
vation and sequestration [9, 51, 53], magnitude of host antibody
or autoantibody production [21, 33, 53, 54], and, lastly, the
accumulation of monocytes/macrophages [55] within the gb-
merular capillaries. The distinct effects of these factors have
been investigated, and it seems that their role in the infliction of
glomerular injury varies from model to model and specie to
specie [56].
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In the past, the glomerular injury or proteinuric response has
been correlated with the amount of heterologous antibodies
bound to the kidney. First, a "nephritogenic threshold" is
needed to be achieved before the glomerular insult can be
perceived [161, and subsequently, the proteinuric response may
be enhanced with increasing dose of the heterologous antibody
administered. Similarly, the proteinuric response in laminin
transplant glomerulopathy [33] is thought to be related to the
very high concentration of the heterologous antibody bound to
the transplanted kidney, which under normal circumstances left
in situ does not get inflicted by the immune injury since the
antibody would be diluted by the circulation or other organs.
Nevertheless, since the sensitization process in the present
model reduced rather than increased the binding of anti-HS-PG
antibodies in the glomerulus, it meant that, most likely, the
glomerular injury or the proteinuric response is not mediated by
the heterologous antibody. Finally, the severity of the glomer-
ular insult and proteinuria may not be related to the amount of
bound heterologous antibody in this model since the proteinuria
was mainly confined to the latter part of the heterologous and
rest of the autologous phase of the disease.
In the NTN model, the heterologous phase injury is regarded
as complement-mediated and leukocyte-dependent, while the
autologous phase proteinuria is considered to be monocyte-
mediated and complement-independent [9, 10, 16, 21]. Since
here one is dealing with an overlap of autologous and heterol-
ogous phases, it is plausible that glomerular proteinuria may
either be due to the additive effect of concomitant cellular
infiltration or, alternatively, due to the activation of the com-
plement system. The latter appears to be applicable since the
proteinuric response could be abrogated by the depletion of the
complement from the serum. However, the depletion did not
influence the deposition of heterologous or autologous antibod-
ies, indicating thereby that the complement per se may have
played a significant role in the induction of glomerular injury
and proteinuria, at least in the early part of the autologous
phase of the disease. The cellular basis of such a complement-
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Fig. 11. Serum antibody (rat anti-rabbit IgG)
titers, as measured by ELISA, of
presensitized and unsensitized animals that
received normal rabbit IgG or rabbit
ant i-HS-PG antibody. With presensitization,
the titers of the antibody (rat anti-rabbit IgG)
are dramatically increased. Symbols are: (A)
presensitized; (•) presensitized plus antibody;6w 7 w 8w (V) presensitized plus normal IgG; (•)
antibody; (•) normal IgG.
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Fig. 12. Effect of cobra venom factor (CVF) on the serum complement
levels and excretion of urinary proteins ofpresensitized animals at various
time intervals after administration of anti-HS-PG antibody. The CVF
dramatically reduces the serum complement levels and concomitantly the
excretion of urinary proteins as compared to the control (CON).
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in the HS-PG model may have been as a result of interactions
between the mesangial cells and factors elaborated by the
monocytes.
Finally, the elucidation of mechanisms, cellular or extracel-
lular, responsible for the dramatic alterations in the form of
irregular thickening of the basement membrane in immune
injury would require complex metabolic studies [64, 65]which
are in progress. It is also anticipated that the availability of this
model may give further impetus for future investigations to
study the immune mechanisms in renal disease.
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